Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Here's a Pure Play in a $25 Billion "Frontier" Market

Chemotherapy and radiation have been cancer treatments since the 1950s, and in the meantime, science has developed more than 200 drugs to fight cancer.

All these established treatments have one thing in common. They're all more or less "one size fits all" treatments, procedures, or regimens.

But out on the frontier of cancer research where, as I've said, the most exciting, promising discoveries (and biggest profits) are made, there's a treatment under development that's going to disrupt the field for the next several decades.

I'm talking about powerful "bespoke" cancer treatments for every patient, using their own bodies to boot.

Not only will this improve and save lives, it'll also crack open a market worth $25 billion by 2025. It really is a revolutionary development.

But the "Buy" call I'm making today is still trading at "pre-revolutionary" prices…

The "A-Bomb" in the Cancer Fight

I can't overstate this. The treatment I'm going to tell you about, as well as the most important company pioneering it, will change cancer treatment the way the atomic bomb changed the face of warfare moving forward.

frontier marketThis biotech "A-bomb" is called immunotherapy, or "IO" to insiders. And it's progressing rapidly.

The technique is straight out of science fiction. Immunotherapy uses a patient's own immune system – "tweaking" it by either suppressing, stimulating, or enhancing an immune response – to effect a desired change. It can be used to vaccinate people and fight microbial diseases, reduce allergic reactions, suppress the sometimes devastating response to organ transplants, and, most promisingly, help patients destroy their own tumors and beat cancer.

Right now there are over 1,000 drug trials underway for IO candidates. The trials are mainly involving patients whose cancer isn't responding to traditional therapies like chemo or radiation and who are now terminal.

There's good reason to move with haste. The longer we live, the more likely we are to develop some form of cancer. It's always been a killer, but it's becoming a huge problem.

In addition to the human cost, treatments are now running about $10,000 a month, according to U.S. News & World Report. Insurers, doctors, researchers, regulators, and patients are all on the same page here. That's been an important driver in IO's development.

I'm bullish on this entire segment, and I'm not alone. Barclays is expecting IO to be worth $25 billion by 2025 – just eight years.

Now let me show you the company I think will reap the most benefit from this "frontier" research drive and incredible momentum.

This Small Company Is at the Top of the Pyramid

Join the conversation. Click here to jump to comments…

About the Author

Michael A. Robinson is one of the top financial analysts working today. His book "Overdrawn: The Bailout of American Savings" was a prescient look at the anatomy of the nation's S&L crisis, long before the word "bailout" became part of our daily lexicon. He's a Pulitzer Prize-nominated writer and reporter, lauded by the Columbia Journalism Review for his aggressive style. His 30-year track record as a leading tech analyst has garnered him rave reviews, too. Today he is the editor of the monthly tech investing newsletter Nova-X Report as well as Radical Technology Profits, where he covers truly radical technologies – ones that have the power to sweep across the globe and change the very fabric of our lives – and profit opportunities they give rise to. He also explores "what's next" in the tech investing world at Strategic Tech Investor.

Read full bio

  1. Just Joe | April 6, 2017

    Canada is going to make the anouncement that they are going legal on Monday 10th April 2017. I wish your pod cast would be sooner.

    • Gerry Sangar | April 9, 2017

      The existing investors in Marijuana stocks will get new buyers at higher rates to make huge profits, these new buyers/investors should wait for at least 8-9 months to exit at the buying prices.They will make huge profits after 3 years. So new investors invest in Marijuana Canada stocks for not less than 5 years from now or wait for 6-7 months from now to invest in Marijuana stocks and try your luck in infrastructure stocks for the coming 6-7 months.

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK